Carbonic Anhydrase IX/CA9 Antibody Blocking Peptide NB100-417PEP from Novus Biologicals, a Bio-Techne Brand

Product Specs
ItemCarbonic Anhydrase IX/CA9 Antibody Blocking Peptide
CompanyNovus Biologicals, a Bio-Techne Brand
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberNB100-417PEP
Concentration1.0 mg/ml
Quantity0.05 ml
Gene Namecarbonic anhydrase IX
NCBI Gene AliasesCAIX, MN
NCBI Full Gene Namecarbonic anhydrase 9
Brand/TrademarkNovus Biologicals, a Bio-Techne Brand
SpeciesHuman
Research AreaCancer, HIF Target Genes, Hypoxia, Lipid and Metabolism, Metastasis, Renal Cell Carcinoma Cell Markers
FormatPeptide dissolved in dH2O. Contains no BSA
Molecule NameCarbonic Anhydrase IX/CA9
ApplicationsAntibody Competition
StorageStore at -80C. Avoid freeze-thaw cycles

Specificity: This peptide is specific for NB 100-417 only

United States: 10771 E Easter Ave

Centennial, Colorado 80112

United States

Phone:
303-730-1950
888-506-6887

Email: novus@novusbio.com

(1) Surface-Enhanced Raman Scattering Nanoparticles for Multiplexed Imaging of Bladder Cancer Tissue Permeability and Molecular PhenotypeACS nanoOctober 23, 2018Davis RM, Kiss B, Trivedi DR, Metzner TJ, Liao JC, Gambhir SS.(Novus Biologicals) was used for CA9 detection. For negative controls the CA9 deactivating peptide (NB100-417PEP, Novus Biologicals) and a mouse IgG1 isotype (product no. MAB002, R&D Biosystems) for CD47 were used. Functionalization

(2) Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomasClinical cancer research : an official journal of the American Association for Cancer ResearchJanuary 1, 2007Yoo H, Baia GS, Smith JS, McDermott MW, Bollen AW, Vandenberg SR, Lamborn KR, Lal A.

Carbonic Anhydrase IX/CA9 Antibody Blocking Peptide from Novus Biologicals, a Bio-Techne Brand